Viking Fund Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.56M | Hold |
20,000
| – | – | 0.21% | 102 |
|
|
2025
Q1 | $1.45M | Hold |
20,000
| – | – | 0.21% | 98 |
|
|
2024
Q4 | $1.48M | Hold |
20,000
| – | – | 0.23% | 99 |
|
|
2024
Q3 | $1.32M | Hold |
20,000
| – | – | 0.21% | 100 |
|
|
2024
Q2 | $1.85M | Hold |
20,000
| – | – | 0.33% | 86 |
|
|
2024
Q1 | $1.91M | Hold |
20,000
| – | – | 0.35% | 87 |
|
|
2023
Q4 | $1.53M | Hold |
20,000
| – | – | 0.3% | 92 |
|
|
2023
Q3 | $1.39M | Hold |
20,000
| – | – | 0.28% | 93 |
|
|
2023
Q2 | $1.89M | Hold |
20,000
| – | – | 0.36% | 89 |
|
|
2023
Q1 | $1.65M | Hold |
20,000
| – | – | 0.32% | 95 |
|
|
2022
Q4 | $1.49M | Hold |
20,000
| – | – | 0.3% | 98 |
|
|
2022
Q3 | $1.65M | Hold |
20,000
| – | – | 0.39% | 90 |
|
|
2022
Q2 | $1.9M | Hold |
20,000
| – | – | 0.44% | 90 |
|
|
2022
Q1 | $2.35M | Hold |
20,000
| – | – | 0.54% | 68 |
|
|
2021
Q4 | $2.59M | Hold |
20,000
| – | – | 0.68% | 49 |
|
|
2021
Q3 | $2.26M | Hold |
20,000
| – | – | 0.66% | 54 |
|
|
2021
Q2 | $2.07M | Hold |
20,000
| – | – | 0.59% | 64 |
|
|
2021
Q1 | $1.67M | Buy |
20,000
+11,000
| +122% | +$920K | 0.5% | 76 |
|
|
2020
Q4 | $821K | Hold |
9,000
| – | – | 0.26% | 104 |
|
|
2020
Q3 | $718K | Hold |
9,000
| – | – | 0.27% | 93 |
|
|
2020
Q2 | $622K | Hold |
9,000
| – | – | 0.23% | 105 |
|
|
2020
Q1 | $566K | Hold |
9,000
| – | – | 0.25% | 91 |
|
|
2019
Q4 | $700K | Hold |
9,000
| – | – | 0.2% | 95 |
|
|
2019
Q3 | $660K | Hold |
9,000
| – | – | 0.19% | 95 |
|
|
2019
Q2 | $554K | Hold |
9,000
| – | – | 0.15% | 105 |
|
|
2019
Q1 | $574K | Hold |
9,000
| – | – | 0.14% | 101 |
|
|
2018
Q4 | $460K | Buy |
+9,000
| New | +$460K | 0.13% | 107 |
|